Skip to main content

vedolizumab (Entyvio®)

 

Status: In progress

Treatment of patients with Immune Checkpoint Inhibitor (ICI) induced grade 3-4 colitis, where symptoms have not responded to first line immunosuppression with corticosteroids and/or other immunosuppressant drugs like infliximab

Medicine details

Medicine name vedolizumab (Entyvio®)
Formulation powder for solution for infusion
Reference number OW22
Indication

As above

Company Takeda UK Ltd
BNF chapter Gastro-intestinal system
Submission type One Wales
Status In progress
Date of issue TBA
Follow AWTTC: